Novo Nordisk warns sales could slide 13% as obesity competition mounts

Novo Nordisk warns sales could slide 13% as obesity competition mounts

Danish drugmaker reports rise in revenues but flags pricing pressure as market becomes more crowded

Leave a Reply

Your email address will not be published. Required fields are marked *

Page Reader Press Enter to Read Page Content Out Loud Press Enter to Pause or Restart Reading Page Content Out Loud Press Enter to Stop Reading Page Content Out Loud Screen Reader Support
WordPress Cookie Plugin by Real Cookie Banner